Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer.
暂无分享，去创建一个
J. Minna | L. Girard | M. Peyton | A. Gazdar | J. Fridman | N. Reguart | Bin-Bing S. Zhou | D. Jablons | P. Scherle | F. Baribaud | I. Mikami | K. Vaddi | Yanlong Li | B. He | Gengjie Yang | S. Friedman | W. Yao | R. Newton | Changnian Liu | Y. Lo | Eian Caudler | Biao He